keyword
https://read.qxmd.com/read/38607317/activated-and-na%C3%A3-ve-allogenic-human-placental-mesenchymal-stromal-cells-exert-an-immunomodulatory-effect-on-hidradenitis-suppurativa-patient-peripheral-blood-mononuclear-cells
#1
JOURNAL ARTICLE
Vaiva Jariene, Paulius Valiukevicius, Justinas Maciulaitis, Ugne Kuzaityte, Ruta Insodaite, Ieva Ciapiene, Romaldas Maciulaitis, Skaidra Valiukeviciene
This pilot study aimed to evaluate the immunomodulatory effect of placental mesenchymal stem/stromal cells (MSCs) on peripheral blood mononuclear cells (PBMCs) from patients with hidradenitis suppurativa (HS). Blood samples were collected from 3 healthy and 3 patients with HS. Isolated PBMCs were stained with carboxyfluorescein succinimidyl ester (CFSE) and stimulated with phorbol 12-myristate 13-acetate (PMA)/Ionomycin solution. The PBMCs of patients with HS were co-cultured with naïve MSCs (n-MSCs), activated with tumor necrosis factor (TNF)-α (10 ng/mL) and interferon (IFN)-γ (10 ng/mL) MSCs (a-MSCs), or adalimumab (30 μg/mL)...
April 12, 2024: Journal of Interferon & Cytokine Research
https://read.qxmd.com/read/38594058/combined-inhibition-of-il-1-il-33-and-il-36-signalling-by-targeting-il1rap-ameliorates-skin-and-lung-fibrosis-in-preclinical-models-of-systemic-sclerosis
#2
JOURNAL ARTICLE
Caitríona Grönberg, Sara Rattik, Cuong Tran-Manh, Xiang Zhou, Aleix Rius Rigau, Yi-Nan Li, Andrea-Hermina Györfi, Nicholas Dickel, Meik Kunz, Alexander Kreuter, Emil-Alexandru Matei, Honglin Zhu, Petter Skoog, David Liberg, Jörg Hw Distler, Thuong Trinh-Minh
BACKGROUND: The interleukin (IL)-1 receptor accessory protein (IL1RAP) is an essential coreceptor required for signalling through the IL-1, IL-33 and IL-36 receptors. Here, we investigate the antifibrotic potential of the combined inhibition of these cytokines by an anti-IL1RAP antibody to provide a scientific background for clinical development in systemic sclerosis (SSc). METHODS: The expression of IL1RAP-associated signalling molecules was determined by data mining of publicly available RNA sequencing (RNAseq) data as well as by imaging mass cytometry...
April 9, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38593108/expanding-the-psoriasis-framework-immunopathogenesis-and-treatment-updates
#3
REVIEW
Yvonne Nong, George Han, Jason E Hawkes
Psoriasis is a chronic heterogeneous condition with multiple available treatment options that have resulted in dramatic disease improvements for patients. IL-23/IL-17 signaling is the central immune signaling pathway driving psoriasis, though recent research has uncovered other key contributing signals such as IL-17C, IL-17F, IL-36, and tyrosine kinase 2 (TYK2). Novel therapeutic targets inhibiting these cytokines have expanded our understanding of the pathogenesis of psoriasis. IL-23/IL-17 signaling is critical for the development of epidermal hyperplasia and the mature psoriatic plaque in susceptible individuals...
February 2024: Cutis; Cutaneous Medicine for the Practitioner
https://read.qxmd.com/read/38577922/alveolar-epithelial-cells-of-lung-fibrosis-patients-are-susceptible-to-severe-virus-induced-injury
#4
JOURNAL ARTICLE
Jane Read, Andrew Reid, Claire Thomson, Marshall Plit, Ross Mejia, Darryl A Knight, Muriel Lize, Karim El Kasmi, Christopher Grainge, Heiko Stahl, Michael Schuliga
Patients with pulmonary fibrosis (PF) often experience exacerbations of their disease, characterised by a rapid, severe deterioration in lung function that is associated with high mortality. Whilst the pathobiology of such exacerbations is poorly understood, virus infection is a trigger.  This study investigated virus-induced injury responses of alveolar and bronchial epithelial cells (AECs and BECs respectively) from patients with PF and age-matched controls (Ctrls).  Air liquid interface (ALI) cultures of AECs, comprising type I and II pneumocytes or BECs were inoculated with influenza A virus (H1N1) at 0...
April 5, 2024: Clinical Science (1979-)
https://read.qxmd.com/read/38577038/targeted-review-of-il36rn-mutations-in-patients-with-generalised-pustular-psoriasis
#5
REVIEW
James G Krueger, Anna Pagotto, Samuel Haftel, Birgit Gradl
BACKGROUND: Generalised pustular psoriasis (GPP) is a rare and chronic skin disease historically treated with therapies that were originally intended to treat plaque psoriasis (PsO). However, GPP and plaque PsO have distinct pathogeneses and clinical courses. OBJECTIVES: This study aimed to further characterise the unique genetic background of GPP by summarising evidence on the frequency and type of IL3 6RN gene mutation, a gene that normally suppresses proinflammatory responses, in patients with GPP compared to patients with GPP and plaque PsO, and patients with plaque PsO only...
April 2024: Skin Health Dis
https://read.qxmd.com/read/38565205/successful-treatment-of-recalcitrant-generalized-pustular-psoriasis-of-pregnancy-with-spesolimab
#6
JOURNAL ARTICLE
Chenxin Yang, Yang Wang, Ruoyu Li, Ping Tu, Ruojun Wang
Generalized pustular psoriasis (GPP) in pregnancy can lead to severe complications for both mother and fetus. The treatment of this disease is challenging, especially in recalcitrant and severe cases. Until present, there are no evidence-based guidelines for the treatment of GPP in pregnancy. Spesolimab, a human monoclonal antibody against the IL-36 receptor, has recently attracted attention as a new therapy for GPP flare. This biologic provides rapid and sustained control of symptoms of GPP flare, although its use in pregnant women has not been reported to date...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38563353/interleukin-1-receptor-accessory-protein-blockade-limits-the-development-of-atherosclerosis-and-reduces-plaque-inflammation
#7
JOURNAL ARTICLE
Megan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, Irena Ljungcrantz, Andrietta Grentzmann, Fong To, Eva Bengtsson, Elin Jaensson Gyllenbäck, Caitríona Grönberg, Sara Rattik, David Liberg, Alexandru Schiopu, Harry Björkbacka, Johan Kuiper, Ilze Bot, Bram Slütter, Daniel Engelbertsen
AIMS: The interleukin-1 receptor accessory protein (IL1RAP) is a co-receptor required for signalling through the IL-1, IL-33, and IL-36 receptors. Using a novel anti-IL1RAP-blocking antibody, we investigated the role of IL1RAP in atherosclerosis. METHODS AND RESULTS: Single-cell RNA sequencing data from human atherosclerotic plaques revealed the expression of IL1RAP and several IL1RAP-related cytokines and receptors, including IL1B and IL33. Histological analysis showed the presence of IL1RAP in both the plaque and adventitia, and flow cytometry of murine atherosclerotic aortas revealed IL1RAP expression on plaque leucocytes, including neutrophils and macrophages...
April 2, 2024: Cardiovascular Research
https://read.qxmd.com/read/38532634/ampk-activation-modulates-il-36-induced-inflammatory-responses-by-regulating-i%C3%AE%C2%BAb%C3%AE-expression-in-the-skin
#8
JOURNAL ARTICLE
Yi-Ting Huang, Ling-Ya Chiu, Po-Hsuan Lu, Pa-Fan Hsiao, Jen-Yu Wang, Ping-Hsun Lu, Nan-Lin Wu
BACKGROUND AND PURPOSE: The interleukin (IL)-36 pathway is a critical player in the pathogenesis of pustular psoriasis. However, therapies targeting this pathway are limited or unaffordable (e.g. the anti-IL-36 receptor antibody). AMP-activated protein kinase (AMPK), a regulator of cellular energy and metabolism, is known to participate in inflammatory diseases. However, its role in IL-36-induced skin inflammation remains unclear. Therefore, we sought to investigate the role of AMPK signals in regulating IL-36-induced responses in the skin...
March 26, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38505140/therapeutic-potential-of-spesolimab-sbzo-in-the-management-of-generalized-pustular-psoriasis-flares-in-adults-evidence-to-date
#9
REVIEW
Federica Rega, Federica Trovato, Giulio Bortone, Giovanni Pellacani, Antonio Giovanni Richetta, Annunziata Dattola
Generalized pustular psoriasis (GPP) is a rare, chronic, and severe skin disorder characterized by the eruption of non-infectious pustules on an erythematous background often associated with systemic symptoms. It may appear in association with plaque psoriasis or occur in previously healthy individuals. It differs from psoriasis vulgaris in clinical presentation, immunopathogenesis, histology, and therapeutic strategies. Overexpression of interleukin 36 (IL-36) or a loss-of-function mutation of IL-36 receptor antagonist (IL-36RA) are thought to play a pivotal role in the pathogenesis of this disease...
2024: Psoriasis: Targets and Therapy
https://read.qxmd.com/read/38467728/serum-il-36%C3%AE-levels-are-associated-with-insulin-sensitivity-in-paediatric-patients-with-obesity
#10
JOURNAL ARTICLE
Paloma Narros-Fernández, Andrew O'Donnell, Clodagh Sheehy, Shrikanth Chomanahalli Basavarajappa, Yasmina Esther Hernandez Santana, David Kinlen, Declan Cody, Andrew E Hogan, Patrick T Walsh
Although the orchestrating role of Interleukin-36 cytokines in regulating inflammation at barrier tissue sites, is well established, whether they play a significant role in the settings of metabolic health and disease, has yet to be fully established. Several recent studies have demonstrated that IL-36 cytokine expression is elevated among adult patients with obesity, and can play roles in regulating both insulin sensitivity and driving inflammation. In this report, we have extended these analyses to paediatric patients and identified an association between elevated serum levels of expression of the specific Interleukin-36 subfamily member, IL-36β, among children with obesity displaying insulin sensitivity, compared to children with obesity who are insulin resistant...
March 11, 2024: International Journal of Obesity
https://read.qxmd.com/read/38464535/successful-treatment-of-acrodermatitis-continua-of-hallopeau-coexisting-with-generalized-pustular-psoriasis-with-spesolimab-a-case-report
#11
Pengfei Wen, Chuan Liu, Tingting Wang, Xian Jiang, Ping Wang, Sheng Wang
Generalized pustular psoriasis (GPP) is a rare chronic inflammatory pustular dermatosis that presents as painful erythema with sterile pustules on nonacral skin. No unified standard and guideline for the treatment of GPP has been established. Several biologics have been tried for GPP, with varying success. Acrodermatitis continua of Hallopeau (ACH) is a very rare disabling variant of pustular psoriasis characterized by sterile pustules on the fingers and toes, including the nail bed. Comparatively, treating ACH is highly challenging due to its commonly therapy-resistant disease course...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38461633/a-therapeutic-strategy-of-parthenolide-in-improving-imiquimod-induced-psoriasis-like-skin-inflammation-targeting-il-36-nets-through-skin-transdermal-therapeutic-system
#12
JOURNAL ARTICLE
Zi-Ying Zhan, Zhi-Hong Zhang, Rong-Hui Sun, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
BACKGROUND: Psoriasis is an inflammatory skin disease that occurs repeatedly over time. The natural product of sesquiterpene lactones, Parthenolide (Par), is isolated from Tanacetum parthenium L. (feverfew) which has significant effects on anti-inflammatory. The therapeutic effect of the medication itself is crucial, but different routes of administration of the same drug can also produce different effects. PURPOSE: The aim of our research sought to investigate the ameliorating effects of Par in psoriasis-like skin inflammation and its related mechanism of action...
March 9, 2024: International Immunopharmacology
https://read.qxmd.com/read/38447274/differential-anti-viral-response-to-respiratory-syncytial-virus-a-in-preterm-and-term-infants
#13
JOURNAL ARTICLE
Jeremy Anderson, Samira Imran, Yan Yung Ng, Tongtong Wang, Sarah Ashley, Cao Minh Thang, Le Quang Thanh, Vo Thi Trang Dai, Phan Van Thanh, Bui Thi Hong Nhu, Do Ngoc Xuan Trang, Phan Thi Phuong Trinh, Le Thanh Binh, Nguyen Thuong Vu, Nguyen Trong Toan, Boris Novakovic, Mimi L K Tang, Danielle Wurzel, Kim Mulholland, Daniel G Pellicci, Lien Anh Ha Do, Paul V Licciardi
BACKGROUND: Preterm infants are more likely to experience severe respiratory syncytial virus (RSV) disease compared to term infants. The reasons for this are multi-factorial, however their immature immune system is believed to be a major contributing factor. METHODS: We collected cord blood from 25 preterm (gestational age 30.4-34.1 weeks) and 25 term infants (gestation age 37-40 weeks) and compared the response of cord blood mononuclear cells (CBMCs) to RSVA and RSVB stimulation using neutralising assays, high-dimensional flow cytometry, multiplex cytokine assays and RNA-sequencing...
March 5, 2024: EBioMedicine
https://read.qxmd.com/read/38423690/generalized-pustular-psoriasis-acute-generalized-exanthematous-pustulosis-and-other-pustular-reactions-a-clinical-review
#14
REVIEW
Elisabeth Gössinger, Roni Dodiuk-Gad, Beda Mühleisen, Hazel H Oon, Choon Chiat Oh, Julia-Tatjana Maul, Alexander A Navarini
Generalized pustular rashes have various etiologies and can be challenging to diagnose and manage at first presentation. The authors provide an in-depth analysis of common pustular skin eruptions including generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis, focusing on their pathophysiology, triggers, clinical presentation, diagnostic challenges, and management strategies. The article also highlights recent advances in genetic research and biologic therapies for GPP and the future directions in personalized medicine and prevention strategies...
April 2024: Dermatologic Clinics
https://read.qxmd.com/read/38419797/generalized-pustular-psoriasis-successfully-treated-with-spesolimab-a-case-report
#15
Noemi Brigenti, Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Generalized pustular psoriasis is defined as a primary, sterile, macroscopically visible pustular eruption on non-acral skin, which can occur with or without systemic inflammation and/or psoriasis vulgaris, and can either be relapsing or be persistent, according to the European Rare and Severe Psoriasis Expert Network. The treatment of generalized pustular psoriasis may be challenging. We describe a 48-year-old woman with a 15-year history of severe generalized pustular psoriasis and plaque psoriasis resistant to multiple courses of treatments with conventional and biological agents who had a rapid, complete and durable (up to 12 months) clinical remission with spesolimab, an anti-interleukin-36 receptor antagonist monoclonal antibody recently approved for the treatment of generalized pustular psoriasis flares...
2024: SAGE Open Medical Case Reports
https://read.qxmd.com/read/38414292/il-36-regulates-neutrophil-chemotaxis-and-bone-loss-at-the-oral-barrier
#16
JOURNAL ARTICLE
J Liu, H Meng, Y Mao, L Zhong, W Pan, Q Chen
Tissue-specific mechanisms regulate neutrophil immunity at the oral barrier, which plays a key role in periodontitis. Although it has been proposed that fibroblasts emit a powerful neutrophil chemotactic signal, how this chemotactic signal is driven has not been clear. The objective of this study was to investigate the site-specific regulatory mechanisms by which fibroblasts drive powerful neutrophil chemotactic signals within the oral barrier, with particular emphasis on the role of the IL-36 family. The present study found that IL-36γ, agonist of IL-36R, could promote neutrophil chemotaxis via fibroblast...
February 27, 2024: Journal of Dental Research
https://read.qxmd.com/read/38414093/increased-neutrophil-derived-il-17a-identified-in-generalized-pustular-psoriasis
#17
JOURNAL ARTICLE
Yu Lan, Xiaoyan Wu, Xinyu Zhong, Pengfei Song, Leying Liu, Yuhua Liu, Xuechen Ai, Changxu Han, Zhenying Zhang
Generalized pustular psoriasis (GPP) is considered to be a distinct clinical entity from psoriasis vulgaris (PV), with different clinical and histological manifestations. The pathogenesis of GPP has not been thoroughly elucidated, especially in those patients lacking interleukin (IL)36RN. In present study, we performed RNA sequence analysis on skin lesions from 10 GPP patients (4 with and 6 without IL36RN mutation) and 10 PV patients without IL36RN mutation. Compared with PV, significantly overexpressed genes in GPP patients were enriched in IL-17 signalling pathway (MMP1, MMP3, DEFB4A and DEFB4B, etc...
February 2024: Experimental Dermatology
https://read.qxmd.com/read/38410244/monitoring-coronary-blood-flow-by-laser-speckle-contrast-imaging-after-myocardial-ischaemia-reperfusion-injury-in-adult-and-aged-mice
#18
JOURNAL ARTICLE
Juma El-Awaisi, Dean P J Kavanagh, Neena Kalia
INTRODUCTION: Investigating coronary microvascular perfusion responses after myocardial infarction (MI) would aid in the development of flow preserving therapies. Laser speckle contrast imaging (LSCI) is a powerful tool used for real-time, non-contact, full-field imaging of blood flow in various tissues/organs. However, its use in the beating heart has been limited due to motion artifacts. METHODS: In this paper, we report the novel use of LSCI, combined with custom speckle analysis software (SpAn), to visualise and quantitate changes in ventricular perfusion in adult and aged mice undergoing ischaemia-reperfusion (IR) injury...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38397412/therapeutic-potential-of-il-1-antagonism-in-hidradenitis-suppurativa
#19
REVIEW
Laura Calabrese, Dalma Malvaso, Giulia Coscarella, Flaminia Antonelli, Alessandra D'Amore, Niccolò Gori, Pietro Rubegni, Ketty Peris, Andrea Chiricozzi
The immunopathogenesis of HS is partially understood and exhibits features of an autoinflammatory disease; it is associated with the potential involvement of B cells and the contribution of Th1 or Th17 cell subsets. Recently, the pathogenic role of both innate immunity and IL-1 family cytokines in HS has been deeply investigated. Several agents targeting the IL-1 family pathway at different levels are currently available and under investigation for the treatment of HS. HS is still characterized by unmet clinical needs and represents an expanding field in the current scientific research...
February 1, 2024: Biomolecules
https://read.qxmd.com/read/38346528/il-36-antagonism-blunts-the-proliferation-and-migration-of-oral-squamous-cell-carcinoma-cells
#20
JOURNAL ARTICLE
Zihui Li, Xiaoxin Zhang, Ke Li, Fuyan Li, Jiahao Kou, Yuhan Wang, Xiaoyue Wei, Yawei Sun, Yue Jing, Yuxian Song, QiuYa Yu, Haijia Yu, Shuai Wang, Shi Chen, Yangtin Wang, Simin Xie, Xiangyang Zhu, Yifan Zhan, Guowen Sun, Yanhong Ni
IL-36 is known to mediate inflammation and fibrosis. Nevertheless, IL-36 signalling axis has also been implicated in cancer, although understanding of exact contribution of IL-36 to cancer progression is very limited, partly due to existence of multiple IL-36 ligands with agonistic and antagonistic function. Here we explored the role of IL-36 in oral squamous cell carcinoma (OSCC). Firstly, we analyzed expression of IL-36 ligands and receptor and found that the expression of IL-36γ was significantly higher in head and neck cancer (HNSCC) than that of normal tissues, and that the high expression of IL-36γ predicted poor clinical outcomes...
February 10, 2024: Cellular Signalling
keyword
keyword
23411
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.